Skip to search.
 FTSE 100 Down 0.67%

More On SKP.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Skyepharma PLC (SKP.L)

-LSE Ticker: 3BFNB6/ISIN: GB00B3BFNB64
278.50 Up 3.50(1.27%) 3 Jul 16:35
Add to Portfolio
Prev Close:275.00
Open:274.75
Bid:278.25
Ask:278.75
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:267.25 - 283.00
52wk Range:229.50 - 379.19
Volume:61,460
Avg Vol (3m):273,223
Market Cap:291.65m
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):0.14
P/S (ttm):390.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :17.57
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Skyepharma PLC develops and sells oral and inhalation pharmaceutical products. The company’s inhalation products include flutiform, a multi-dose pressurized metered dose inhaler for the treatment of bronchial asthma; Anoro Ellipta and Incruse... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback